Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.08m04718yel
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Physicians Postgraduate Press, Inc

Related search

Patients With Chronic Gastrointestinal Ischemia Have a Higher Cardiovascular Disease Risk and Mortality

Atherosclerosis
Cardiovascular MedicineCardiology
2012English

Long-Term Treatment With Clozapine in Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
1996English

Higher Risk of Cardiovascular Mortality in Young Edentulous Patients Treated With Dental Implants

Clinical Oral Implants Research
Oral Surgery
2017English

Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in Chronic Kidney Disease Patients

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2019English

Waist Circumference Is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients With Schizophrenia Treated With Clozapine but Not Olanzapine

Journal of Psychiatric Practice
PsychiatryMental Health
2009English

Decreased Cardiovascular and Extrahepatic Cancer-Related Mortality in Treated Patients With Mild HFE Hemochromatosis

Journal of Hepatology
Hepatology
2015English

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
2018English

Use of Clozapine in Brazilian Patients With Parkinson's Disease

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2008English

The Brain Metabolic Patterns of Clozapine- And Fluphenazine-Treated Female Patients With Schizophrenia Evidence of a Sex Effect

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy